Brazil doesn't lack rules to discipline bank credit. The National Monetary Council issues resolutions on Total Effective Cost transparency, the Central Bank publishes monthly average rates, and the Superior Court of Justice has settled central issues like interest capitalization and tied selling. The regulatory architecture exists, is sophisticated, and on paper protects the business borrower reasonably well. So why, case after case, does a systemic pattern of irregularity keep showing up?
In this analysis
A robust rulebook — and an uncomfortable question
Brazil doesn't lack rules to discipline bank credit. The National Monetary Council issues resolutions on Total Effective Cost transparency, on risk classification of operations, on good client-relationship practices. The Central Bank publishes, every month, average interest rates by product and institution. The Superior Court of Justice has settled, over decades, central issues such as interest capitalization, tied selling, and fee charging. The regulatory architecture exists, is sophisticated, and on paper protects the business borrower reasonably well.
The question a recurring technical forensic audit of business credit contracts is forced to ask, after reviewing dozens of operations, is a different one: why, despite that architecture, does a systemic irregularity pattern keep showing up, case after case, bank after bank, product after product?
What the forensic sample's numbers suggest
Across twenty business-credit operations submitted to technical forensic review — CCBs, revolving credit lines, and one commercial note, involving ten different lending institutions — a few patterns appear with a frequency that can't be attributed to chance or an isolated case of mismanagement:
| Pattern identified | Frequency in the sample (20 cases) |
|---|---|
| Effective rate above the Central Bank's market average | 20 of 20 (100%) |
| Interest capitalization during grace or default period | 17 of 20 (85%) |
| Error or opacity in the IOF excise-tax calculation | 9 of 20 (45%) |
| Collateral stacking with no rate discount | 9 of 20 (45%) |
| PIX/TED sweep of third-party funds | 7 of 20 (35%) |
In all twenty cases reviewed, the interest rate actually charged was above the market average the Central Bank itself reports for the equivalent product — in many cases substantially above, even in operations with a public guarantee or strong real collateral that, technically, should justify a lower rate, not a higher one.
In seventeen of the twenty cases, some form of interest capitalization was identified during a grace or default period — the unlawful compounding that Precedent 121 of Brazil's Supreme Federal Court has barred since 1963, except under express legal exceptions, and which, six decades later, remains the most recurring technical pathology in business credit contracts.
In nine of the twenty cases, an error or opacity was identified in calculating the IOF excise tax — a tax whose methodology is set by federal decree, not the bank's discretion, and whose systematic error in nearly half the sample suggests an internal-control failure, not a one-off exception.
Could your credit contract show any of these patterns?
Request a preliminary technical screening to check rate, IOF, and interest capitalization.
Where supervision seems to fall short
The institutional critique offered here isn't that the Central Bank is entirely absent — the agency regulates, publishes data, and works on relevant fronts, such as the design of credit-guarantee programs themselves. The critique is more specific: there's a noticeable gap between prudential supervision, focused on solvency and systemic stability, and conduct supervision, focused on how each individual contract is structured and priced for the end client.
That gap shows up in concrete places. The Central Bank publishes average rates by product but doesn't appear to systematically cross-check those averages against the individual CET of fomento credit operations to verify whether an emergency program's regulatory ceiling — created as a protective exception — is being charged as the standard over-the-counter rate. Supervision of the methodology for calculating IOF financed within the principal appears to rely more on after-the-fact litigation than on upfront compliance audits. And oversight of automatic checking-account fund-capture practices (PIX/TED sweep, present in seven of the twenty cases) remains without specific regulation requiring minimal upfront transparency to the client.
Policy design versus practice enforcement
One point deserves technical emphasis: the public fomento programs (PRONAMPE, FGI-PEAC, BNDES Automático) are well designed as credit policy. The problem isn't the policy's architecture — it's the absence of a real-time, or near-real-time, mechanism to verify that the rate and collateral structure each bank applies in each individual operation respect the program's spirit. A guarantee fund covering 80% of the risk, whose mitigation isn't reflected in the final price charged to the borrower, is a public policy whose benefit is being partially captured by the lender, not the intended beneficiary — with no apparent systematic audit of that capture.
What more effective supervision could do
Technically, a few measures seem feasible within the existing regulatory structure:
- Periodic sample audits of the CET on fomento credit operations, cross-checking the charged rate against the program's ceiling and the Central Bank's average rate for the product.
- Requiring upfront, specific transparency about sweep and unrestricted automatic-debit mechanisms, today treated as generic boilerplate in adhesion contracts.
- A simplified verification channel, accessible to small companies, for independently checking the IOF calculation before signing.
None of these measures require new legislation. They require a supervisory priority shift. And the question the forensic sample leaves open is precisely that: if a pattern shows up in 100% of the cases that reach a forensic audit, how many others — that never reach a technical opinion — are simply being paid without contest?
This article is part of a series on technical pathologies in business credit operations, based on expert opinions prepared by the author. Individual cases are treated in aggregate and anonymized form, with no identification of the companies or individuals involved.
Frequently asked questions
Does Brazil's Central Bank regulate business banking credit?
Yes. Brazil's National Monetary Council issues rules on Total Effective Cost transparency and risk classification, and the Central Bank publishes average interest rates by product and institution every month. The regulatory architecture exists and is sophisticated, but there's a noticeable gap between prudential supervision and individual conduct supervision of each contract.
Why do irregularity patterns keep appearing despite robust regulation?
Because the Central Bank's supervision is mostly prudential, focused on solvency and systemic stability, and doesn't systematically cross-check published average rates against each credit operation's individual CET, nor does it audit in advance the methodology for calculating the financed excise tax (IOF) or automatic checking-account sweep mechanisms.
What does Brazil's Supreme Court Precedent 121 have to do with business credit today?
Precedent 121 of Brazil's Supreme Federal Court has barred interest capitalization since 1963, except under express legal exceptions. Six decades later, unlawful compounding remains the most recurring technical pathology in business credit contracts, showing up in 85% of a recent forensic-audit sample.
What supervisory measures could reduce this irregularity pattern?
Periodic sample audits of the CET on fomento credit operations, cross-checked against the program's ceiling and the Central Bank's average rate; requiring upfront, specific transparency about sweep and unrestricted automatic-debit mechanisms; and a simplified channel for independently verifying the IOF calculation before signing.